医学
内科学
曲妥珠单抗
人口
胃肠病学
临床终点
肺癌
临床研究阶段
肿瘤科
癌症
临床试验
外科
乳腺癌
环境卫生
作者
Kōichi Goto,Yasushi Goto,Toshio Kubo,Kiichiro Ninomiya,Sang‐We Kim,David Planchard,Myung‐Ju Ahn,Egbert F. Smit,Adrianus J. de Langen,M. Pérol,Elvire Pons‐Tostivint,Silvia Novello,Hidetoshi Hayashi,Junichi Shimizu,Dong‐Wan Kim,Chih‐Hsi S. Kuo,James Chih‐Hsin Yang,Kaline Pereira,Fu-Chih Cheng,Ayumi Taguchi
摘要
Trastuzumab deruxtecan (T-DXd) 5.4 and 6.4 mg/kg showed robust antitumor activity in multiple cancer indications; however, T-DXd 5.4 mg/kg has not been evaluated in patients with previously treated human epidermal growth factor receptor 2-mutant (
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
yznfly
Dritsw
完美的友蕊
lzx
张雷
pluto
dodo
典雅碧空
要好好看文献
归尘
iNk
今天不学习明天变垃圾
deallyxyz
64658
眼睛大雨筠
SYLH
8R60d8
pcr163
研友_ngkyGn
May
皖公网安备34019202002308
